🌱 KidneyEnergy.com

Today's nuggets

The day's findings, chosen and worded by a panel of AI editors, and every one carries its evidence grade. Not medical advice; bring it to your nephrologist.

2026-08-13 · 5 nuggets

Weight loss drugs may affect longevity and skin health

GLP-1 receptor agonists (RAs) used for weight loss may influence longevity and skin health. This review discusses potential benefits and risks for aging populations

Why it matters: These medications could impact long-term healthspan and aesthetic outcomes

C Peer reviewed Slowing decline · source ↗

SGLT2 inhibitors reduce risk of kidney failure in diabetes patients

These drugs lower the risk of kidney and heart failure. They may increase urinary tract infections or cause ketoacidosis, a serious-but-rare blood acid buildup. Use with caution in patients with-low-normal-kidney function.

Why it matters: Using these drugs can help prevent kidney failure and heart failure in patients with diabetes

A Peer reviewed Slowing decline · source ↗

GLP-1 drugs may cause loss of lean muscle mass

Weight loss treatments using GLP-1 receptor agonists may reduce muscle mass. This risk is higher in patients with sarcopenia (low muscle mass relative to weight) or low-muscle weight

Why it matters: Maintaining muscle mass is vital for physical function and longevity, especially in patients with kidney disease

C Peer reviewed Slowing decline · source ↗

A protein receptor linked to kidney damage

The prorenin receptor affects kidney damage and blood pressure. It is a potential target for drugs to slow kidney decline.

Why it matters: Targeting this receptor could help delay the progression of kidney disease. Evidence: small-scale trials

B Peer reviewed Slowing decline · source ↗

BPA exposure linked to kidney damage risk

Exposure to bisphenol A (BPA), a chemical used in plastics, is associated with kidney damage. This risk applies to both patients with and without dialysis requirements.

Why it matters: Reducing exposure to plastics may help slow kidney disease progression

C Peer reviewed Slowing decline · source ↗

How these are made: three AI editors nominate the day's findings from different angles (strongest evidence, most useful, most hopeful), an editor-in-chief picks the final set, then a writer and two critics debate the clearest, most honest wording. All on local models. What the grades mean →